TASC-3B (Trace element ATORG Study COVID-19 in Berlin, Bavaria, and Baden-Württemberg): Characterization of COVID-19 infections using parameters of the immune system and trace element status
Recruiting
- Conditions
- 07.1 COVID-19
- Registration Number
- DRKS00022294
- Lead Sponsor
- Klinikum Aschaffenburg-Alzenau gemeinnützige GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Reasonable suspicion of COVID-19 infection RKI
- Detection of a COVID-19 infection via RT-PCR
- patient's consent
Exclusion Criteria
- No patient consent
- Age under 18 years
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severe course of COVID-19 infection;<br>Indicators: interstitial pneumonia, ARDS
- Secondary Outcome Measures
Name Time Method ength of stay in the hospital, duration of treatment in the intensive care unit, ventilation required during the course, duration of ventilation.